B
Evidence Grade B
Graded
accuracy verified by the review judge
Safe to Cite
Dated
70%
70% -- prescribing intent rate for Amjevita among gastroenterologists and rheumatologists (2023)
70% of surveyed gastroenterologists and rheumatologists are likely to prescribe Amjevita in some capacity.
- Small sample size of 30 healthcare professionals
- Follows a payer-dependent approach
Attribution:
View source
Lighthouse Research Team
Last verified:
·
How we verify data →
Source verified
Evidence graded
Value
70%
Unit
Percentage
Data Vintage
2023
Entity
Sample Size
30
Geography
US
Evidence Quality
B
Strong, reliable evidence
Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.
Single source - not yet corroborated
Score breakdown
Extraction
95
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
Source
ZoomRx
Primary
Tier A
https://blog.zoomrx.com/launch-excellence/the-launch-of-amjevita-the-first-humira-biosimilar/ ↗
Source Article
The Launch of Amjevita: The First Humira Biosimilar
The world of autoimmune treatments has seen a new addition with the launch of Amjevita, the first Humira biosimilar. Humira, the swiss knife medication, has been available in the US since 2002 and has been a game-changer in treating various autoimmune conditions. With the advent of biosimilars, pati…
Original Research
ZoomRx
· Original study ↗
Methodology
ZoomRx survey panel of 30 gastroenterologists and rheumatologists
Methodology documented
Segmentation
IndustryHealthcare
RegionUS
RoleAll marketers
Channelmulti-channel
Cite this stat
Plain Text
Amjevita among gastroenterologists and rheumatologists: 70% prescribing intent rate. Source: ZoomRx (2023). Via Lighthouse Intelligence -- https://lighthousedata.io/data/amjevita-prescribing-intent-hcp-2023
HTML Embed
<blockquote cite="https://lighthousedata.io/data/amjevita-prescribing-intent-hcp-2023" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>70%</strong> -- prescribing intent rate for Amjevita among gastroenterologists and rheumatologists<br><small>Source: ZoomRx (2023) · <a href="https://lighthousedata.io/data/amjevita-prescribing-intent-hcp-2023" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.